Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia

Respirology

Volumn 19, Issue 5, 2014, Pages 748-754

  Papakosta, Despina ^a   Manika, Katerina ^a   Gounari, Evdoxia ^a   Kyriazis, George ^a   Kontakiotis, Theodore ^a   Spyropoulos, George ^a   Kontakioti, Eirini ^a   Zarogoulidis, Konstantinos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

bronchoalveolar lavage fluid; cryptogenic organizing pneumonia; hypersensitivity pneumonitis; NK cell; NKT like cell

Indexed keywords

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; BLOOD; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CELL COUNT; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG LAVAGE; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PATHOGENESIS; PRIORITY JOURNAL; BLOOD CELL; CASE CONTROL STUDY; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CYTOLOGY; LUNG; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; BLOOD CELLS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CRYPTOGENIC ORGANIZING PNEUMONIA; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KILLER CELLS, NATURAL; LUNG; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; PROSPECTIVE STUDIES;

EID: 84903178154     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12305     Document Type: Article

References (37)

1. American Thoracic Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification on the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
2. Nagai S, Handa T, Ito Y, Takeuchi M, Izumi T,. Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin. Respir. Crit. Care Med. 2007; 28: 496-503. (Pubitemid 350036960)
3. Ksienzyk A, Neumann B, Nandakumar R, Finsterbusch K, Grashoff M, Zawatzky R, Bernhardt G, Hauser H, Kröger A,. IRF-1 expression is essential for natural killer cells to suppress metastasis. Cancer Res. 2011; 71: 6410-6418.
4. Li F, Zhu H, Sun R, Wei H, Tian Z,. Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J. Virol. 2012; 86: 2251-2258.
5. Message SD, Johnston SL,. The immunology of virus infection in asthma. Eur. Respir. J. 2001; 18: 1013-1025. (Pubitemid 34092878)
6. Korsgren M, Persson CG, Sundler F, Bjerke T, Hansson T, Chambers BJ, Hong S, Van Kaer L, Ljunggren HG, Korsgren O,. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 1999; 189: 553-562. (Pubitemid 29187377)
7. Rijavec M, Volarevic S, Osolnik K, Kosnik M,. Natural killer T cells in pulmonary disorders. Respir. Med. 2011; 105 (S1): S20-25.
8. Hwang SJ, Kim S, Park WS, Chung DH,. IL-4 secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-γ producing neutrophils. J. Immunol. 2006; 177: 5258-5268. (Pubitemid 44527598)
9. Tomura M, Yu WG, Ahn HJ, Yamashita M, Yang YF, Ono S, Hamaoka T, Kawano T, Taniguchi M, Koezuka Y, et al. A novel function of Vα14+ CD4+ NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 1999; 163: 93-101. (Pubitemid 29295829)
10. Otani T, Nakamura S, Toki M, Motoda R, Kurimoto M, Orita K,. Identification of IFN-γ producing cells in IL-12/IL-18-treated mice. Cell. Immunol. 1999; 198: 111-119. (Pubitemid 30086127)
11. Iizuka A, Ikarashi Y, Yoshida M, Heike Y, Takeda K, Quinn G, Wakasugi H, Kitagawa M, Takaue Y,. Inteleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell derived interferon0gamma and IL-4. Immunology 2008; 123: 100-107. (Pubitemid 350256003)
12. Papakosta D, Kyriazis G, Gioulekas D, Kontakiotis T, Polyzoni T, Bouros D, Patakas D,. Variations in alveolar cell populations, lymphocyte subsets and NK cells in different stages of active pulmonary sarcoidosis. Sarc. Vasc. Diffuse. Lung Dis. 2005; 22: 21-26. (Pubitemid 40444730)
13. Papakosta D, Manika K, Kyriazis G, Kontakiotis T, Gioulekas D, Polyzoni T, Bouros D, Patakas D,. Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias. Respiration 2009; 78: 177-184.
14. Korosec P, Rijavec M, Silar M, Kern I, Kosnik M,. Osolnik K. Deficiency of pulmonary Valpha24Vbeta11 natural killer T cells in corticosteroid-naïve sarcoidosis patients. Respir. Med. 2010; 104: 571-577.
15. Korosec P, Osolnik K, Kern I, Silar M, Mohorcic K, Kosnik M,. Expansion of pulmonary CD8+ CD56+ natural killer T-cells in hypersensitivity pneumonitis. Chest 2007; 132: 1291-1297. (Pubitemid 47621006)
16. Segawa S, Goto D, Yoshiga Y, Horikoshi M, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T,. Involvement of NK 1.1-positive γδT cells in interleukin -18 plus interleukin-2-induced interstitial lung disease. Am. J. Respir. Cell Mol. Biol. 2011; 45: 659-666.
17. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pekkanen R, Muller N, Colby TV, Schuyler M, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 2003; 168: 952-958. (Pubitemid 37267173)
18. American Thoracic Society. American Thoracic Society, European Respiratory Society: idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am. J. Respir. Crit. Care Med. 2000; 161: 646-664.
19. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788-824.
20. Klech H, Pohl W,. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur. Respir. J. 1989; 2: 2.
21. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am. J. Respir. Crit. Care Med. 2012; 185: 1004-1014.
22. Woda BA,. Hypersensitivity pneumonitis. An immunopathology review. Arch. Pathol. Lab. Med. 2008; 132: 204-205.
23. Jimenez-Alvarez L, Zúñiga J, Gaxiola M, Checa M, Becerril C, Mendoza F, Pardo A, Selman M,. Inflammatory response and dynamics of T cell sbsets in Th1, Th2 biased and Th2 deficient mice during the development of hypersensitivity pneumonitis. Exp. Mol. Pathol. 2010; 88: 407-415.
24. Ye Q, Dai H, Sarria R, Guzman J, Costabel U,. Increased expression of tumor necrosis factor receptors in cryptogenic organizing pneumonia. Respir. Med. 2011; 105: 292-297.
25. Lopez AD, Avasarala S, Grewal S, Murali AK, London L,. Differential role of the Fas/fas ligand apoptotoc pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia ans acute respiratory distress syndrome. J. Immunol. 2009; 183: 8244-8257.
26. Drakopanagiotakis F, Polychronopoulos V, Judson MA,. Organizing pneumonia. Am. J. Med. Sci. 2008; 335: 34-39.
27. Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V,. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest 2011; 139: 893-900.
28. Cordier JF,. Update on cryptogenic organizing pneumonia (idiopathic bronchiolitis obliterans organizing pneumonia). Swiss. Med. Wkly. 2002; 132: 588-591.
29. Vasu TS, Cavallazzi R, Hirani A, Sharma D, Weibel SB, Kane GC,. Clinical and radiologic distinctions between secondary bronchiolitis obliterans organizing pneumonia and cryptogenic organizing pneumonia. Respir. Care 2009; 54: 1028-1032.
30. Ismail T, McSharry C, Boyd G,. Extrinsic allergic alveolitis. Respirology 2006; 11: 262-268.
31. Costabel U, Teschler H, Guzman J,. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur. Respir. J. 1992; 5: 791-797.
32. Capelozzi VL, Faludi EP, Balthazar AB, Fernezlian SD, Filho JV, Parra ER,. Bronchoalveolar lavage improves diagnostic accuracy in patients with diffuse lung disease. Diagn. Cytopathol. 2013; 41: 1-8.
33. Kim JH, Chung DH,. CD1d-restricted INF-γ secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1α production and activation of macrophages and dendritic cells. J. Immunol. 2011; 186: 1432-1441.
34. Esposito I, Perna F, Ponticello A, Perella M, Gilli M, Sanduzzi A,. Natural killer cells in Bal and peripheral blood of patients with idiopathic pulmonary fibrosis (IPF). Int. J. Immunopathol. Pharmacol. 2005; 18: 541-545. (Pubitemid 41532369)
35. Kim JH, Kim HY, Kim S, Chung JH, Park WS, Chung DH,. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-γ. Am. J. Pathol. 2005; 167: 1231-1241. (Pubitemid 41541410)
36. Papiris SA, Kollintza A, Karatza M, Manali ED, Sotiropoulou C, Milic-Emili J, Roussos C, Daniil Z,. CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis. J. Inflamm. 2007; 4: 14.
37. Daniil Z, Kitsanta P, Kapotsis G, Mathioudaki M, Kollintza A, Karatza M, Milic-Emili J, Roussos C, Papiris SA,. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Respir. Res. 2005; 6: 81.